Cancer Institute Clinician Resources
At Providence Cancer Institute, we work together with referring clinicians to give our patients compassionate, well-coordinated and personalized care. We partner with you from diagnosis and treatment through all stages of life, ensuring an excellent patient experience and seeking the best outcomes through evidence-based medicine, research and innovation.
We make it easy to refer your patient by connecting you with the right specialist within the Providence Cancer Institute network. Call our Provider and Patient Engagement Center for assistance with finding a service or provider: 503-215-6014.
Clinics using Epic can refer with Epic codes. Non-Epic clinics can call or fax referrals.
Telephone consultations
1-844-ASK-PROV (1-844-275-7768)
- Scope: Outpatient & non-urgent
- Availability: Mon - Fri: 8 a.m. - 4:30 p.m.
- Response time: Immediate or same day callback
Non-documented consultation for advice, interpreting results and referrals
Online consultations
Epic electronic message consult is located under the “Helper” navigator.
- Scope: Outpatient & non-urgent
- Availability: 24 hours / 7 days a week
- Response time: 1 - 2 business days
Formal documentation non-visit consultation for advice, interpreting results and referrals
Telephone Patient Transfer for Acute Care
1-503-216-7768 (1-888-777-9599)
- Scope: Inpatient & urgent
- Availability: 24 hours / 7 days a week
- Response time: Immediate
- Functions:
- Request to transfer a patient
- Acute care
- Emergent and interventional service line
When your patient is facing a potential cancer diagnosis, we’re here for you. We welcome you as part of our multidisciplinary team personalizing your patient’s care plan to their unique diagnosis and care needs.
Our team of hematology and medical oncology experts utilize chemotherapy, hormone therapy, targeted therapy and immunotherapy to treat cancer and hematologic conditions. We collaborate closely with Providence Genomics lab and the Earle A. Chiles Research Institute to be at the forefront of treatment innovations.
Our team of surgeons and surgical oncologists manage all aspects of surgical care for a wide range of cancers and benign conditions. Visit Providence Cancer Institute of Oregon for more information about the surgical services and treatments that we offer for your patient’s diagnosis.
Our team of radiation oncology experts offer extraordinary care using state-of-the-art technologies such as high-dose rate (HDR) brachytherapy, MRI-guided linear accelerators and Gamma Knife.
Providence Cancer Institute is proud to offer multidisciplinary cancer conferences to help providers discuss diagnoses, treatment planning and other case-specific topics. The conferences are located in the Portland Service Area but offer remote access for health care providers through Microsoft Teams technology.
Providence Cancer Institute's virtual oncology lectures provide busy clinicians with critical updates and clinical pearls from experts they can trust. We designed these live, educational opportunities to facilitate collaboration with primary and specialty care teams on the latest best practices in patient care.
Lectures are scheduled during lunchtime through Microsoft Teams and will focus on a specific oncology topic with a Q+A session at the end.
We publish monthly Classic Heme Hot Topics articles written by Christine Johnson, M.D., a hematology oncology specialist with Providence Cancer Institute. Each article addresses various classical hematology topics and answers questions currently relevant to primary care physicians.
- Find articles, event details and early announcements from Providence Cancer Institute.
- Read the latest clinical insights from Providence experts on InScope Publication.
- Sign up for our monthly newsletter, Finish Cancer Through Research.
- Connect with us via:
As the research arm of Providence Cancer Institute in Portland, Oregon, the Earle A. Chiles Research Institute is an established pioneer, a recognized Center of Excellence and a global leader in precision immuno-oncology and cellular therapy. Our contributions towards the advancement of cancer treatments earned a Nobel Prize in medicine and established immunotherapy as a standard of care for many cancer treatments.
For over 25 years, our research has been at the forefront of immunotherapy, which is made possible largely by the generosity of our donors. Today, we have over 45,000 square feet dedicated to our lab research and core facilities, where our team of scientists and clinical researchers work together to seamlessly join cancer research and medical practice.
With access to cutting-edge immunotherapy medicines and treatments currently in development, our patients are often among the first to benefit from groundbreaking clinical trials. Our clinical research portfolio is extensive, and many trials we offer aren’t available anywhere else on the West Coast. We’re a global leader in immunotherapy and remain steadfast in our commitment to develop improved cancer treatments and to #FINISHCANCER.
Strategic Alliances
Providence Cancer Institute has a strategic alliance with MJH Life Sciences to bring you up to date information, resources and education from our trusted cancer experts, and more:
See Our Latest News
